Jan. 2 (Bloomberg) — IMS Health Holdings Inc., the health care focused information technology company taken private four years ago, filed for a $100 million initial public offering.

The figure is a placeholder used to calculate fees and may change. IMS, backed by Canada Pension Plan Investment Board, TPG Capital and Leonard Green & Partners LP, plans to use the funds for a proposed debt refinancing, according to today's regulatory filing. JPMorgan Chase & Co., Goldman Sachs Group Inc. and Morgan Stanley are managing the IPO.

IMS, which provides prescription data to drugmakers and analysts, posted $1.9 billion in revenue for the first nine months of 2013, with operating margins of 15 percent, according to the filing. The Danbury, Connecticut-based company was said to be considering an IPO as well as a sale process as of last month, possibly seeking a valuation of at least $8 billion, according to people familiar with the situation.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.